Wycliffe Raduma is a seasoned product development professional with deep expertise in design engineering and production—particularly in the realm of medical devices. Born in Kenya and raised in Finland, he is currently leading the commercialization of Otos, a Finland-based spin-out

Armon Sharei is the CEO and Founder of Portal Biotechnologies, an early-stage cell engineering platform company based in Cambridge, MA.

Initially, we wanted to solve the chaos many SMEs face with fragmented tools: invoices in one app, accounting in another, payroll via email… it was a mess. Our vision was to create a unified ecosystem that handles everything from A

At Novaliq, we research and develop water-free eye drops—a unique and, at first glance, almost counterintuitive innovation. When I first learned about Novaliq in 2016, I was immediately intrigued. It raised a fundamental question: why, after thousands of years, are

Tell us more about yourself and what motivated you to found Arxx, which has since become Calluna Pharma following the merger with Oxitope. I was born in Norway and lived there until I moved to Copenhagen to study medicine. I

You have an extensive background in both academia and the biotech industry, with over 60 peer-reviewed papers and multiple patents. How has your experience as a researcher shaped your approach as a life sciences investor and entrepreneur? I think it

Can you share the inspiration and vision behind founding Kadence Bio? The inspiration for Kadence Bio stemmed from our founders’ early investigations into potential acute treatments for mood disorders, where they explored different classes of alkaloid small molecules. We discovered

You are a chartered accountant turned biotech Founder-CEO. Can you share your journey with us? After graduating with a Bachelor of Science in Finance, I trained to become a Chartered Accountant with PwC. I later secured a role as a